SEC 13F Intelligence

Blackhill Capital Inc / ABT

Blackhill Capital Inc’s Abbott Laboratories Position

Does Blackhill Capital Inc own Abbott Laboratories (ABT)? Yes — 268.5K shares worth $28M (+1.42% of its 13F portfolio) as of Q1 2026.

Position Value
$28M
Q1 2026
Shares
268.5K
% of Portfolio
+1.42%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $25MQ4 ’18Q1 ’19: $28MQ2 ’19: $28MQ3 ’19: $28MQ4 ’19: $29MQ4 ’19Q1 ’20: $26MQ2 ’20: $30MQ3 ’20: $35MQ4 ’20: $35MQ4 ’20Q1 ’21: $39MQ2 ’21: $37MQ3 ’21: $38MQ4 ’21: $45MQ4 ’21Q1 ’22: $37MQ2 ’22: $34MQ3 ’22: $29MQ4 ’22: $33MQ4 ’22Q1 ’23: $31MQ2 ’23: $33MQ3 ’23: $29MQ4 ’23: $33MQ4 ’23Q1 ’24: $34MQ2 ’24: $31MQ3 ’24: $34MQ4 ’24: $34MQ4 ’24Q1 ’25: $40MQ2 ’25: $38MQ3 ’25: $36MQ4 ’25: $34MQ4 ’25Q1 ’26: $28Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026268.5K$28M+1.42%
Q4 2025268.5K$34M+1.73%
Q3 2025268.2K$36M+1.78%
Q2 2025278.2K$38M+2.18%
Q1 2025298.2K$40M+2.30%
Q4 2024298.2K$34M+1.75%
Q3 2024298.2K$34M+1.96%
Q2 2024298.2K$31M+1.92%
Q1 2024298.2K$34M+1.95%
Q4 2023298.2K$33M+2.63%
Q3 2023298.2K$29M+2.78%
Q2 2023298.6K$33M+3.49%
Q1 2023301.2K$31M+3.40%
Q4 2022301.2K$33M+3.83%
Q3 2022301.2K$29M+3.46%
Q2 2022311.9K$34M+3.93%
Q1 2022314.1K$37M+3.54%
Q4 2021322.1K$45M+3.88%
Q3 2021322.8K$38M+3.30%
Q2 2021322.8K$37M+3.41%
Q1 2021322.8K$39M+3.37%
Q4 2020322.8K$35M+4.26%
Q3 2020322.8K$35M+4.75%
Q2 2020325.2K$30M+4.38%
Q1 2020327.8K$26M+5.39%
Q4 2019329.6K$29M+4.18%
Q3 2019333.3K$28M+4.41%
Q2 2019338.4K$28M+4.58%
Q1 2019348.4K$28M+4.78%
Q4 2018348.4K$25M+4.83%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Blackhill Capital Inc’s full portfolio or all institutional holders of ABT.